{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/coeliac-disease/background-information/prevalence/","result":{"pageContext":{"chapter":{"id":"13d4bc73-968e-5163-b7b1-3a66b2f0e52c","slug":"prevalence","fullItemName":"Prevalence","depth":2,"htmlHeader":"<!-- begin field f957bfdc-d56c-41c9-993b-6ecac0f67efc --><h2>How common is it?</h2><!-- end field f957bfdc-d56c-41c9-993b-6ecac0f67efc -->","summary":"","htmlStringContent":"<!-- begin item 508f7ff2-8ef3-4e9e-8a98-2b805a7060f5 --><!-- begin field b4d982f8-d7dc-4ceb-9b52-31176765fa3a --><p><strong>Coeliac disease is under-diagnosed, and it is estimated that for every person diagnosed, seven to eight people remain undiagnosed </strong>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Mooney, 2014b</a>]<strong>. The prevalence data for coeliac disease varies according to the population studied, sample size, and disease definition </strong>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">West, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Singh, 2018</a>]<strong>.</strong></p><ul><li>The prevalence of coeliac disease has increased over the past 50 years [<a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Lebwohl, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Al-Toma, 2019</a>].<ul><li>A large-scale European population screening study (n = 29,212 adults and children) from Finland, Italy, Germany, and the UK reported a prevalence of around 1%, using serological testing and inclusion of people who were previously diagnosed [<a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Mustalahti, 2010</a>].<ul><li>The study noted that prevalence rates varied significantly in adults across different countries, being highest in Finland and lowest in Germany.</li></ul></li><li>A European Society for the Study of Coeliac Disease guideline notes [<a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Al-Toma, 2019</a>]:<ul><li>The increase in new cases may be partially due to improved diagnostic tools, and through screening of people considered to be at high risk.</li><li>In western countries, the prevalence is around 1% with serological screening of the general population, and 0.6% in histologically confirmed cases.</li><li>It affects all age groups, including the elderly, with more than 70% of new cases diagnosed in people over 20 years of age.</li></ul></li><li>A large UK population-based primary care study (1990–2011) found a total of 9087 incident cases of coeliac disease, equating to an overall incidence rate of 13.8 per 100,000 person-years. The incidence rate increased four-fold over the study period, from 5.2 per 100,000 to 19.1 per 100,000 person-years, and there were large regional variations in prevalence [<a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">West, 2014</a>].<ul><li>About 3 in 10,000 children under 5 years of age were diagnosed.</li><li>About 4 in 1000 adults over the age of 70 years were diagnosed.</li><li>The increase in incidence was theorized to be due to improvements in the identification and diagnosis of coeliac disease over the study period.</li></ul></li></ul></li><li>Various studies have found a female preponderance in cases of coeliac disease.<ul><li>A meta-analysis of 96 studies found [<a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Singh, 2018</a>]:<ul><li>The pooled global prevalence was 1.4% (n = 275,818) based on serology testing.</li><li>The pooled global prevalence was 0.7% (n = 138,792) based on biopsy testing.</li><li>The prevalence was higher in females than in males (0.6% compared with 0.4%).</li></ul></li><li>A meta-analysis of 50 studies found [<a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">King, 2020</a>]:<ul><li>The global pooled female incidence was 17.4 per 100,000 person-years, compared with 7.8 in males.</li><li>The global incidence in children was 21.3 per 100,000 person-years, compared with 12.9 in adults.</li><li>The incidence of coeliac disease has increased by 7.5% per year over the past several decades.</li></ul></li><li>A US study found coeliac disease is more frequently diagnosed in women than in men with a ratio between 1.5:1 and 2:1, and the incidence rates increased with age and over time [<a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Murray, 2003</a>].</li></ul></li><li>Expert opinion in a review article notes that coeliac disease can occur at any age from early childhood to old age, with two peaks of onset; one shortly after weaning with gluten in the first 2 years of life, and the other in the second or third decades of life [<a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Caio, 2019</a>].</li></ul><!-- end field b4d982f8-d7dc-4ceb-9b52-31176765fa3a --><!-- end item 508f7ff2-8ef3-4e9e-8a98-2b805a7060f5 -->","topic":{"id":"1c1a5a3f-9b4d-5aca-b1c7-548672455692","topicId":"b0551c5c-9ab6-4db2-b8e5-27b98c6108ac","topicName":"Coeliac disease","slug":"coeliac-disease","lastRevised":"Last revised in May 2020","chapters":[{"id":"1ab49395-0a38-5106-ac8c-081d06df8957","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"42fe31c7-8b64-527e-bd5e-51c32714ee29","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"26b08904-13dc-5b32-8bc4-2549fa573fb3","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"5c0dee49-ba90-52f3-a99a-676cb4ca5418","slug":"changes","fullItemName":"Changes"},{"id":"875d3bb9-e2eb-51af-b90b-a59a08a4c149","slug":"update","fullItemName":"Update"}]},{"id":"9ced2297-bd68-58b0-b12e-d660074f8e9e","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"394005c9-726f-5f88-be40-717a7d0adb86","slug":"goals","fullItemName":"Goals"},{"id":"2f234477-2111-51de-8800-18b0231b7b5c","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"82c4f886-1b62-5a2f-b956-e939a3736a77","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"352349eb-c34b-5c8a-8f35-cc52c1e427e0","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"ba3abfa3-9c4f-527d-bc4a-30d501245cb7","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"67796a49-6946-5a26-9be6-3d4e8ae58914","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"f7799373-9e95-51e7-beb7-1fecaaa38b46","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"d877907c-0181-5747-953a-1057a01509ee","slug":"definition","fullItemName":"Definition"},{"id":"13d4bc73-968e-5163-b7b1-3a66b2f0e52c","slug":"prevalence","fullItemName":"Prevalence"},{"id":"f33b46df-e16f-5d24-a608-1b5b4a4b605a","slug":"causes","fullItemName":"Causes"},{"id":"09a61360-9601-5caa-84af-2136bd4a7603","slug":"complications","fullItemName":"Complications"},{"id":"9db3868a-f808-5034-8563-58a2c84ab545","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"13e9616c-5ad7-54a8-af68-dad57366685f","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"77ada14b-2c51-5bf2-894b-526f099ef23e","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"d056d742-1aa4-57bc-8e9b-3730a715a6dd","slug":"assessment","fullItemName":"Assessment"},{"id":"98e1c8e5-e970-57a5-a01e-0d4ad52bc8ca","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"4561ec77-0c01-5346-8f45-78e225038140","fullItemName":"Management","slug":"management","subChapters":[{"id":"ee522102-0563-555f-a5b5-a9199c67b6a8","slug":"management-of-confirmed-coeliac-disease","fullItemName":"Scenario: Management of confirmed coeliac disease"}]},{"id":"e9edb239-af7b-54d7-ad64-dadf49939e27","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"bc5fb8ef-a4c4-581b-8828-fa524bfc69ca","slug":"gluten-free-products","fullItemName":"Gluten-free products"}]},{"id":"76c25337-4d0a-5036-b7cf-1c7ca39a7e48","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"6001d4b8-f58d-5d70-a396-3f47044d6a24","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"cf74b6f9-a29b-5108-b99b-0d2d5782850a","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"472110e6-ab58-582f-8614-7d056d174365","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"4c098beb-df9b-5e8d-8fdf-0197b1dd54d3","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"9a97c354-b836-5bab-8cbf-eb9d5698f9cb","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"a79c40d9-503b-5914-bb11-f0370fa4119a","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"aa655679-10e1-5946-87a1-3dfdf6ad91f3","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"f7799373-9e95-51e7-beb7-1fecaaa38b46","slug":"background-information","fullItemName":"Background information"},"subChapters":[]}}},"staticQueryHashes":["3666801979"]}